| Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects JC Ray, M Kapoor, RJ Stark, SJ Wang, L Bendtsen, M Matharu, EJ Hutton Journal of Neurology, Neurosurgery & Psychiatry 92 (12), 1325-1334, 2021 | 42 | 2021 |
| Inflammatory complications of CGRP monoclonal antibodies: a case series JC Ray, P Allen, A Bacsi, JJ Bosco, L Chen, M Eller, H Kua, LL Lim, ... The journal of headache and pain 22, 1-8, 2021 | 33 | 2021 |
| OnabotulinumtoxinA in migraine: a review of the literature and factors associated with efficacy JC Ray, EJ Hutton, M Matharu Journal of clinical medicine 10 (13), 2898, 2021 | 20 | 2021 |
| Cytokines in primary headache disorders: a systematic review and meta-analysis AK Musubire, S Cheema, JC Ray, EJ Hutton, M Matharu The Journal of Headache and Pain 24 (1), 36, 2023 | 17 | 2023 |
| Association of neurocritical care services with mortality and functional outcomes for adults with brain injury: a systematic review and meta-analysis X Pham, J Ray, AS Neto, J Laing, P Perucca, P Kwan, TJ O’Brien, AA Udy JAMA neurology 79 (10), 1049-1058, 2022 | 16 | 2022 |
| Neurological implications of COVID-19: a review of the science and clinical guidance L Tan, ZC Lin, J Ray, R Wesselingh, TJ Oxley, J McFadyen, M Kapoor, ... BMJ neurology open 2 (2), 2020 | 10 | 2020 |
| The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature JC Ray, X Pham, E Foster, S Cheema, SJ Corcoran, MS Matharu, ... Cephalalgia 42 (11-12), 1274-1287, 2022 | 9 | 2022 |
| Subacute cerebellar degeneration due to a paraneoplastic phenomenon associated with metastatic Merkel cell carcinoma: a case report A Sharobeam, J Ray, J Dong, V Chong Case Reports in Oncology 10 (2), 764-768, 2017 | 9 | 2017 |
| Cluster headache in adults JC Ray, RJ Stark, EJ Hutton Australian prescriber 45 (1), 15, 2022 | 7 | 2022 |
| Making migraine easier to stomach: the role of the gut− brain− immune axis in headache disorders M Sgro, J Ray, E Foster, R Mychasiuk European Journal of Neurology 30 (11), 3605-3621, 2023 | 6 | 2023 |
| Intravenous lidocaine and ketamine infusions for headache disorders: a retrospective cohort study JC Ray, S Cheng, K Tsan, H Hussain, RJ Stark, MS Matharu, E Hutton Frontiers in Neurology 13, 842082, 2022 | 6 | 2022 |
| Imaging in headache disorders JC Ray, EJ Hutton Australian Prescriber 45 (3), 88, 2022 | 5 | 2022 |
| New daily persistent headache: a systematic review and meta-analysis S Cheema, D Mehta, JC Ray, EJ Hutton, MS Matharu Cephalalgia 43 (5), 03331024231168089, 2023 | 4 | 2023 |
| The state of migraine:'An update on current and emerging treatments' JC Ray, C Macindoe, M Ginevra, EJ Hutton Australian Journal of General Practice 50 (12), 915-921, 2021 | 4 | 2021 |
| Autonomic symptoms in migraine: Results of a prospective longitudinal study JC Ray, S Cheema, E Foster, L Gunasekera, D Mehta, SJ Corcoran, ... Frontiers in Neurology 13, 1036798, 2022 | 3 | 2022 |
| Neuroimaging in visual snow-a review of the literature S Raviskanthan, JC Ray, PW Mortensen, AG Lee Frontiers in Ophthalmology 2, 758963, 2022 | 3 | 2022 |
| Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial JC Ray, Z Chen, G Ramsay, J Germaine, EJ Hutton BMJ open 12 (3), e059647, 2022 | 2 | 2022 |
| Polyneuritis cranialis from varicella zoster virus reactivation JA Schnall, SF Khan, L Zolio, JC Ray, AWJ Jenney The Medical Journal of Australia 213 (8), 352-353. e1, 2020 | 2 | 2020 |
| The short-term effects of CGRP monoclonal antibodies on bone turnover: a prospective cohort study JC Ray, S Sztal-Mazer, J Baker, MS Matharu, EJ Hutton Cephalalgia 43 (6), 03331024231180562, 2023 | 1 | 2023 |
| Migraine in 2022: an update on management RJS Tamsin Hilliard, Jason C Ray, Elspeth J Hutton Medicine Today 23 (9), 57-64, 2022 | 1* | 2022 |
